OLDAKER & WILLISON, LLP for JUUL LABS, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 16, 2021 | $48,000 | Replaced |
| 1st Quarter - Amendment | Apr 19, 2021 | $48,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 22, 2021 | $36,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. ___/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access. H.R. ___/S.___, Labor, Health and Human Services, and Related Agencies Appropriations Act, FY 2022; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of enhanced access controls to combat underage access.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW B. WILLISON | — |
Tobacco TOB
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW B. WILLISON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.